Dr Ellen Hatch

I have been at the University of Leicester since May 2021. Previous to this I was the Course Director for BSc. Pharmacology at Coventry University.

I hold a BSc. In Biomedical sciences specialising in Pharmacology and MSc Molecular genetics and PhD in Pharmacogenetics from Newcastle University. I have experience of teaching and student supervision in a range of Biomedical subjects at level 4-7 and course management at a number of Universities within the UK.

My other roles include academic support tutor, PPDG Medical School representative and a member of the assessment team. I am a member of the British Pharmacology Society, British Society for Immunology and the UK Stratified medicine group.  I am a qualified mental health first aider.  

My PhD was in personalised medicine specifically investigating the tailoring of dose to an individual's genetic and personal profile. This is an area I still have a keen interest in and one of the areas in which I teach. As an early career researcher I worked in many fields, including renal immunology and dermatology and have a wide range of technical experience.

I have established collaborations with both Newcastle and Coventry University. I have a particular interest in Mitochondrial damage, oxidative stress and the use of antioxidants to prevent damage including off target cardiac damage.

Lane S, Al-Zubiedi S, Hatch E, Matthews I, Jorgensen AL, Deloukas P, Daly AK, Park BK, Aarons L, Ogungbenro K, Kamali F, Hughes D, Pirmohamed M. The Population Pharmacokinetics of R and S-Warfarin: Effect of Genetic and Clinical Factors. Br J Clin Pharmacol. Jan: 2012 73 (1): 66-76
Tang Z, Lu B, Hatch E, Sacks SH, Sheerin NS. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol. 2009 Mar;20(3):593-603.
Hatch E, Wynne H, Avery P, Wadelius M, Kamali F. Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients. J Thromb Haemost. 2008 Jun: 6 (6):1038-40.
Hatch, E., E. A. Sconce, A. K. Daly, and F. Kamali, A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene. J Thromb Haemost, 2006. 4 1158-9.

I am the co lead for the Immune unit within the Medical school. My main areas of teaching are within Pharmacology, Physiology and Molecular biology. 

Previous experience includes:

Conference presentations include:

Meyer, D.V., Green, E.F., Birch-Machin, M.A,  Hatch, E. Tiron is Protective Against ROS-induced Damage in Human Bronchial Epithelial Cells. Poster. Reactive oxygen species and lipid peroxidation in human health and disease HNE club meeting. Graz Austria

Chiuzbaian, O., Gharanei, M., Mee, C., Maddock, H., Hatch, E Antioxidant Tiron protects against Doxorubicin-Induced Cardiotoxicity. Poster  BPS (2016)

Meyer, D.V., Green, E.F., Birch-Machin, M.A,  Hatch, E. Tiron Offers Protection Against H2O2-Induced Mitochondrial DNA Damage. Poster  BPS (2016)

Chiuzbaian, O., Gharanei, M., Mee, C., Maddock, H., Hatch, E   Antioxidant Tiron protects against Doxorubicin-Induced Cardiotoxicity. Safety Pharmacology Society Vancouver Poster (2016)

Chiuzbaian, O., Gharanei, M., Mee, C., Maddock, H., Hatch, E Does Tiron offer cardio protection from myocardial injury induced Doxorubicin? BPS Poster (2015)

Chiuzbaian, O., Gharanei, M., Mee, C., Maddock, H., Hatch, E  Tiron offers protection from Doxorubicin induced myocardial injury. Safety Pharmacology Society Meeting-Prague Poster (2015)

Hatch E., Ingham V.J., Parker L., Smith A., Kirby J., Sheerin N. Infiltrating renal T cells are activated and respond to self antigen. In: Immunology: Annual Congress of the British Society for Immunology., Liverpool, UK: (2011) Wiley-Blackwell Publishing Ltd. Poster.

Hatch, E., Tang, Z., Lu, B., Sacks, S.H. and Sheerin, N.S. The roles of C3a and C5a complement receptors in the development of renal fibrosis. Institute of cellular medicine, University of Newcastle Oral presentation (2010).

Hatch, E., S. Darbyshire, E. A. Sconce, B. King, H.A. Wynne, A. K. Daly, and F. Kamali, Polymorphisms in genes associated with the vitamin K epoxide reductase complex do not affect warfarin dose requirement. British Pharmacological society winter meeting December 2006 Oxford. (also presented as a poster at the ESF PGX conference Sant Feliu de Guixols, Spain 2007)

Hatch, E., E. A. Sconce, A. K. Daly, and F. Kamali, A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1). British Pharmacological society winter meeting December 2005 London. Pfizer poster communication prize.

2021 SfHEA

2012 – 2014   PgCert Higher Education Professional Practice

2004 – 2007 Ph.D Clinical Pharmacology University of Newcastle Upon Tyne. Variability in response to warfarin: analysis of pharmacogenetic and environmental factors 

2003 – 2004 M.Sc. (Hons) in Molecular Genetics.  University of Leicester.

2000–2003  B.Sc. (Hons)  in Biomedical Sciences specialising in Pharmacology. University of Bradford.